Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Hepatol. 2011 Apr 14;55(6):1281–1290. doi: 10.1016/j.jhep.2011.03.017

Figure 1. Hepatic overexpression of cPLA2α prevents Fas-induced liver injury.

Figure 1

The cPLA2α Tg mice and their age/sex-matched wild type mice were injected intraperitoneally with a single dose of purified hamster anti-mouse Fas monoclonal antibody Jo2 (0.5 μg/g body weight) to induce hepatocyte apoptosis. (A) Survival curve of wild type and cPLA2α Tg mice after Jo2 injection. The cPLA2α Tg (n=10) and wild type mice (n=10) at 8-10 weeks of age received an intraperitoneal injection of Jo2 and the animals were closely monitored for activity and survival. (B) Gross photographs of liver taken 4 hours and 6 hours after Jo2 injection. The livers of wild type mice turned to dark red after Jo2 injection because of massive hepatic hemorrhage, which was observed at 4 hour and became much more prominent at 6 h. In contrast, the livers of cPLA2α Tg mice were completely normal at 4 h and became slightly red at 6 h. (C) Serum levels of ALT and AST at 4 h and 6 h after Jo2 injection. Blood samples were collected and sera were separated for transaminase analysis. The cPLA2α Tg mice show significantly lower serum ALT and AST levels than the wild type mice after Jo2 treatment. The data are expressed as mean ±SD from 6 mice (*p<0.01 vs. corresponding cPLA2α Tg mice, Student’s t test).